儿童急性淋巴细胞白血病化疗后发热抗感染的药学监护  

Pharmaceutical Care in Anti-Infection Treatment of Children with Fever after Chemotherapy of Acute Lymphoblastic Leukemia

作　　者：黄建权[1] 孙华君[1] 

机构地区：[1]上海市儿童医院,上海200040

出　　处：《儿科药学杂志》2017年第5期35-37,共3页Journal of Pediatric Pharmacy

基　　金：上海交通大学医学院2016年度医院药学科研基金重点项目;编号JDYX2016ZD005;上海交通大学医工交叉课题;编号YG2015QN29

摘　　要：目的:通过参与急性淋巴细胞白血病(ALL)患儿化疗后抗感染治疗过程,探讨儿科临床药师在ALL治疗中的作用。方法:临床药师对1例化疗后发热的ALL患儿进行抗菌药物用药监护,为临床制定抗感染治疗方案提供建议。结果:临床药师协助临床医师正确合理地使用抗菌药物,ALL患儿好转出院。结论:临床药师参与ALL患儿抗感染治疗方案的制定,进行药学监护,可提高抗菌药物临床应用的合理性。Objective： To explore the role of clinical pharmacists in the treatment of anti-infection of children with fever after chemotherapy of acute lymphoblastic leukemia. Methods： Clinical pharmacists supplied the pharmaceutical care for one case of antimicrobial treatment after chemotherapy of acute lymphoblastie leukemia, provided recommendations for the clinical development of anti infection treatment program. Results： Clinical pharmacists made the proper judgment to assist clinicians to use antibiotics correctly and rationally, and this child was discharged from the hospital. Conclusion： Clinical pharmacists can improve the rationality of clinical application of antibiotics with participating in the formulation of anti-infection treatment program, to carry out pharmaceutical

关 键 词：急性淋巴细胞白血病 骨髓抑制 发热 抗菌药物 药学监护 

分 类 号：R969.3[医药卫生—药理学]